Premium
ADC Therapeutics SA (ADCT)
NYSE
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
| Fin d'année 31 Décembre 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Return on Assets (%) | -169.207 | -75.622 | -40.653 | -27.163 | -53.063 |
| Return on Equity (%) | -209.587 | -110.281 | -91.718 | -122.285 | 788.028 |
| Return on Invested Capital (%) | -215.515 | -90.418 | -96.289 | -79.762 | -463.103 |
| Operating Margin (%) | -4946.41 | N/A | -687.458 | -56.09 | -214.345 |
| Net Profit Margin (%) | -4977.949 | N/A | -678.203 | -74.223 | -337.165 |
| Book Value Per Share | 1.972 | 4.238 | 3.897 | 0.835 | -1.801 |
| Earnings Per Share | -2.236 | -3.208 | -5.878 | -1.75 | -2.85 |
| Cash Per Share | 2.218 | 5.721 | 11.921 | 3.666 | 3.385 |
| Working Capital Per Share | 1.971 | 5.341 | 11.531 | 3.898 | 3.264 |
| Operating Profit Per Share | 0.077 | N/A | 0.832 | 2.307 | 0.829 |
| EBIT Per Share | -2.225 | -3.204 | -6.427 | -1.737 | -2.375 |
| EBITDA Per Share | -2.225 | -3.204 | -6.427 | -1.737 | -2.375 |
| Free Cash Flow Per Share | -2.226 | -3.197 | -5.782 | -1.75 | -2.825 |
| Fin d'année 31 Décembre 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A |
| Actions en circulation | 52,1M | 76,77M | 39,14M | 89,04M | 82,29M |
| Fin d'année 31 Décembre 2023 | |||||
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Actions en circulation | N/A | ||||
| Return on Assets (%) | N/A | ||||
| Return on Equity (%) | N/A | ||||
| Return on Invested Capital (%) | N/A | ||||
| Operating Margin (%) | N/A | ||||
| Net Profit Margin (%) | N/A | ||||
| Sales Per Share | N/A | ||||
| Book Value Per Share | N/A | ||||
| Earnings Per Share | N/A | ||||
| Cash Per Share | N/A | ||||
| Working Capital Per Share | N/A | ||||
| Operating Profit Per Share | N/A | ||||
| EBIT Per Share | N/A | ||||
| EBITDA Per Share | N/A | ||||
| Free Cash Flow Per Share | N/A | ||||
| Current Ratio | N/A | ||||
| Quick Ratio | N/A | ||||
| Inventory Turnover (Days) | N/A |
| Capitalisation boursière | 231,09M |
| Ratio cours/bénéfice | -0,88 |
| Ratio prix/ventes | 2,96 |
| Ratio prix/liquidités | 0,74 |
| Ratio prix/valeur comptable | -1,39 |
| Rendement de dividende | - |
| Actions en circulation | 96,69M |
| Volume moyen (1 semaine) | 533,59k |
| Volume moyen (1 mois) | 392,19k |
| Variation sur 52 semaines | 184,04% |
| Plus haut sur 52 semaines | 6,04 |
| Plus bas sur 52 semaines | 0,684 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
